Iran Daru (XTEH:IRDR1) EV-to-EBITDA : (As of Jun. 14, 2024)

View and export this data going back to 1990. Start your Free Trial

What is Iran Daru EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Iran Daru's enterprise value is IRR0.00 Mil. Iran Daru does not have enough years/quarters to calculate its EBITDA for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Iran Daru's EV-to-EBITDA at this moment.

The historical rank and industry rank for Iran Daru's EV-to-EBITDA or its related term are showing as below:

XTEH:IRDR1's EV-to-EBITDA is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 14.445
* Ranked among companies with meaningful EV-to-EBITDA only.

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-14), Iran Daru's stock price is IRR12710.00. Iran Daru does not have enough years/quarters to calculate its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Iran Daru's PE Ratio at this moment.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.

Iran Daru EV-to-EBITDA Historical Data

The historical data trend for Iran Daru's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Iran Daru EV-to-EBITDA Chart

Iran Daru Annual Data

Trend

EV-to-EBITDA

Iran Daru Semi-Annual Data

EV-to-EBITDA

Competitive Comparison of Iran Daru's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Iran Daru's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Iran Daru's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Iran Daru's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Iran Daru's EV-to-EBITDA falls into.

Iran Daru EV-to-EBITDA Calculation

Iran Daru's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA	=	Enterprise Value (Today)	/	EBITDA (TTM)
	=	0.000	/
	=

Iran Daru (XTEH:IRDR1) EV-to-EBITDA Explanation

Iran Daru's PE Ratio for today is calculated as:

PE Ratio	=	Share Price (Today)	/	Earnings per Share (Diluted) (TTM)
	=	12710.00	/
	=

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Iran Daru EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Iran Daru's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Iran Daru (XTEH:IRDR1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Iran Daru (XTEH:IRDR1) » Definitions » EV-to-EBITDA

Comparable Companies

Traded in Other Exchanges

N/A

Address

Ayatollah Saeedi Highway, End Of Kermani Street, Moallem Boulevard, Tehran, IRN, 1371658111

Website

https://www.irandaru.com

Iran Daru is a pharmaceutical company based in Iran. It manufactures and sells pharmaceutical products for antibiotics, cardiovascular agents, and local anesthetic agents. The company manufactures products in three main dosage form categories namely solid, semi-solid, and liquid including tablets, capsules, pellets, sachets, gels, creams, ointments (sterile and non-sterile), spray solutions, and syrups. Products offered by Iran Daru include Diclofenac Potassium, Biotin 5 mg, Tetracycline, Folic acid, Meloxicam, Acetaminophen and Caffeine, and Levocetirizine dihydrochloride, among others. It also exports its products to other countries.

Iran Daru (XTEH:IRDR1) Headlines

No Headlines